Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |